Dialysis

Eurofins Scientific has acquired Ascend Clinical LLC, the largest independent laboratory for dialysis testing in the United States, according to a press release. Terms were not disclosed.

Nephrology practices could leave the Kidney Care Choices model for patients with chronic kidney disease because of planned reductions in Medicare payments that are “much larger than anticipated,” according to a nephrology advocacy group.

Patients with chronic kidney disease and normoalbuminuria had higher risk for disease progression that increased in a linearly relationship with higher albuminuria levels, according to data.

A kidney failure risk equation model had acceptable discrimination and calibration, and “better clinical utility” than an eGFR-based strategy to assess kidney failure rates in Chinese patients, according to a study in Kidney Medicine.

The autosomal dominant polycystic kidney disease registry may help assess various aspects of disease burden on patients’ health-related quality of life, according to published research.

Deprescribing through clinical decision support along with providing safety brochures may be an effective method to address potentially inappropriate medications for patients on dialysis.

Patients with rare kidney diseases have greater 5-year rates of kidney failure but higher survival than those with chronic kidney disease stages 3 through 5, according to published data.

In its biannual report to Congress, the Medicare Payment Advisory Commission recommended that payments to physicians should increase but a planned 1.8% boost in the bundled payment rate for dialysis services was adequate for 2025.

The American Society of Nephrology and Home Dialysis University are offering scholarships to improve home therapies education for nephrology fellows, according to a press release.

Patients with chronic kidney disease may have difficulty accessing equitable treatment even in a country with universal health care, according to published findings.